News + Filings Transactions
|
SHAFFER CHRISTY L
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/23/2023 | CalciMedica, Inc. | GRAY | Disposition | Restricted Stock Unit | 1.4k | $0.00 | $0 | | 03/23/2023 |
| 03/23/2023 | CalciMedica, Inc. | GRAY | Disposition | Common Stock | 1.4k | $0.00 | $0 | | 03/23/2023 |
| 06/22/2022 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 30k | $1.62 | $48.6k | | 06/22/2022 |
| 06/02/2022 | CalciMedica, Inc. | GRAY | Grant | Stock Option (Right to Buy) | 20k | $0.98 | $19.7k | | 06/02/2022 |
| 06/02/2022 | CalciMedica, Inc. | GRAY | Grant | Restricted Stock Units | 20k | $0.00 | $0 | | 06/02/2022 |
| 06/10/2021 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 25k | $3.11 | $77.8k | | 06/10/2021 |
| 06/02/2021 | CalciMedica, Inc. | GRAY | Grant | Employee Stock Option (Right to Buy) | 12.5k | $4.07 | $50.9k | | 06/02/2021 |
| 09/29/2020 | CalciMedica, Inc. | GRAY | Conversion | Series C Preferred Stock | 151.1k | $0.00 | $0 | See footnote | 09/29/2020 |
| 09/29/2020 | CalciMedica, Inc. | GRAY | Conversion | Series B Preferred Stock | 1.2M | $0.00 | $0 | See footnote | 09/29/2020 |
| 09/29/2020 | CalciMedica, Inc. | GRAY | Conversion | Series A-2 Preferred Stock | 193.2k | $0.00 | $0 | See footnote | 09/29/2020 |
| 09/29/2020 | CalciMedica, Inc. | GRAY | Purchase | Common Stock | 18.8k | $16.00 | $300k | See footnote | 09/29/2020 |
| 09/29/2020 | CalciMedica, Inc. | GRAY | Conversion | Common Stock | 1.6M | $0.00 | $0 | See footnote | 09/29/2020 |
| 06/18/2020 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 25k | $2.00 | $50k | | 06/18/2020 |
| 06/20/2019 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 20k | $1.07 | $21.4k | | 06/20/2019 |
| 06/20/2018 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 11.2k | $10.74 | $120.8k | | 06/20/2018 |
| 11/30/2017 | G1 Therapeutics, Inc. | GTHX | Other (disposition) | Common Stock | 99.5k | $0.00 | $0 | By L2 Ventures, LLC | 11/30/2017 |
| 11/30/2017 | G1 Therapeutics, Inc. | GTHX | Other (acquisition) | Common Stock | 995 | $0.00 | $0 | By Hatteras Venture Advisors V, LLC | 11/30/2017 |
| 08/15/2017 | Clearside Biomedical, Inc. | CLSD | Purchase | Common Stock | 1.1k | $7.00 | $7.7k | | 08/15/2017 |
| 07/11/2017 | G1 Therapeutics, Inc. | GTHX | Grant | Stock Option (right to buy) | 20k | $15.55 | $311k | | 07/11/2017 |
| 06/30/2017 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 2.6k | $9.11 | $24k | | 06/30/2017 |
| 06/22/2017 | Clearside Biomedical, Inc. | CLSD | Grant | Stock Option (right to buy) | 8.6k | $8.81 | $75.9k | | 06/22/2017 |
| 05/22/2017 | Clearside Biomedical, Inc. | CLSD | Purchase | Common Stock | 1.1k | $8.00 | $8.8k | | 05/23/2017 |
| 05/22/2017 | G1 Therapeutics, Inc. | GTHX | Conversion | Common Stock | 99.5k | $0.00 | $0 | By L2 Ventures, LLC | 05/22/2017 |
| 05/22/2017 | G1 Therapeutics, Inc. | GTHX | Conversion | Series B Preferred Stock | 172.3k | $0.00 | $0 | See Footnote | 05/22/2017 |
| 05/22/2017 | G1 Therapeutics, Inc. | GTHX | Conversion | Series C Preferred Stock | 126.2k | $0.00 | $0 | See Footnote | 05/22/2017 |
| 03/20/2017 | Clearside Biomedical, Inc. | CLSD | Purchase | Common Stock | 2.2k | $6.90 | $15.2k | | 03/20/2017 |
| 11/11/2009 | INSPIRE PHARMACEUTICALS INC | ISPH | Grant | Stock Option (Right to Buy) | 29.5k | $5.10 | $150.4k | | 11/11/2009 |
|